Tango Therapeutics, Inc. (TNGX)
NASDAQ: TNGX · Real-Time Price · USD
3.630
-0.450 (-11.03%)
At close: Nov 21, 2024, 4:00 PM
3.710
+0.080 (2.20%)
After-hours: Nov 21, 2024, 7:03 PM EST

Tango Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Net Income
-123.4-101.74-108.18-58.24-51.97-14.1
Depreciation & Amortization
2.52.421.610.90.720.64
Loss (Gain) From Sale of Investments
-6.13-3.39----
Stock-Based Compensation
26.3119.0814.237.831.761.69
Other Operating Activities
3.743.631.751.320.890.48
Change in Accounts Receivable
-2---2-
Change in Accounts Payable
1.24-1.711.11.231.17-0.98
Change in Unearned Revenue
-31.28-31.53-16.86-12.04119.08-14.25
Change in Other Net Operating Assets
4.7-6.73-2.73-0.540.421.7
Operating Cash Flow
-122.32-117.98-109.08-59.5370.07-24.8
Capital Expenditures
-0.86-1.53-7.69-1.84-1.11-1.82
Investment in Securities
68.7742.9534.09-181.6-144.322.67
Other Investing Activities
-----0.04-
Investing Cash Flow
67.9241.4326.4-183.43-145.470.85
Issuance of Common Stock
48.482.651.621.060.04-
Other Financing Activities
-0.24-0.24-0.01326.28--
Financing Cash Flow
48.1682.411.62357.3380.8811
Net Cash Flow
-6.245.85-81.07114.365.49-12.96
Free Cash Flow
-123.18-119.51-116.77-61.3668.97-26.62
Free Cash Flow Margin
-283.93%-327.18%-469.72%-165.66%900.84%-108.00%
Free Cash Flow Per Share
-1.14-1.26-1.33-0.992.16-2.96
Levered Free Cash Flow
-62.54-61.82-48.74-34.02-18.57-
Unlevered Free Cash Flow
-62.54-61.82-48.74-34.02-18.57-
Change in Net Working Capital
3.1810.43-12.534.54-12.68-
Source: S&P Capital IQ. Standard template. Financial Sources.